TY - JOUR
T1 - Xiaoxuming Decoction
T2 - A Traditional Herbal Recipe for Stroke With Emerging Therapeutic Mechanisms
AU - Zhang, Qian
AU - Wang, Yue
AU - Chen, Aiwen
AU - Huang, Xinwei
AU - Dong, Qianyu
AU - Li, Zhen
AU - Gao, Xiaofei
AU - Wu, Tingmei
AU - Li, Wanrong
AU - Cong, Peilin
AU - Wan, Hanxi
AU - Dai, Danqing
AU - He, Mengfan
AU - Liang, Huazheng
AU - Wang, Shaoshi
AU - Xiong, Lize
N1 - Funding Information:
This work was supported by a grant from the Shanghai Fourth People’s Hospital (2019001).
Funding Information:
This work was supported by a grant from the Shanghai Fourth People?s Hospital (2019001).
Publisher Copyright:
Copyright © 2021 Zhang, Wang, Chen, Huang, Dong, Li, Gao, Wu, Li, Cong, Wan, Dai, He, Liang, Wang and Xiong.
PY - 2021/12/14
Y1 - 2021/12/14
N2 - Xiaoxuming decoction (XXMD) has been traditionally used to manage stroke though debates on its clinical efficacy were present in the history. Till nowadays, it is still one of the most commonly used herbal recipes for stroke. One of the reasons is that a decent proportion of ischemic stroke patients still have residue symptoms even after thrombolysis with rt-PA or endovascular thrombectomy. Numerous clinical studies have shown that XXMD is an effective alternative therapy not only at the acute stage, but also at the chronic sequelae stage of ischemic stroke. Modern techniques have isolated groups of compounds from XXMD which have shown therapeutic effects, such as dilating blood vessels, inhibiting thrombosis, suppressing oxidative stress, attenuating nitric oxide induced damage, protecting the blood brain barrier and the neurovascular unit. However, which of the active compounds is responsible for its therapeutic effects is still unknown. Emerging studies have screened and tested these active compounds aiming to find individual compounds that can be used as drugs to treat stroke. The present study summarized both clinical evidence of XXMD in managing stroke and experimental evidence on its molecular mechanisms that have been reported recently using advanced techniques. A new perspective has also been discussed with an aim to provide new targets that can be used for screening active compounds from XXMD.
AB - Xiaoxuming decoction (XXMD) has been traditionally used to manage stroke though debates on its clinical efficacy were present in the history. Till nowadays, it is still one of the most commonly used herbal recipes for stroke. One of the reasons is that a decent proportion of ischemic stroke patients still have residue symptoms even after thrombolysis with rt-PA or endovascular thrombectomy. Numerous clinical studies have shown that XXMD is an effective alternative therapy not only at the acute stage, but also at the chronic sequelae stage of ischemic stroke. Modern techniques have isolated groups of compounds from XXMD which have shown therapeutic effects, such as dilating blood vessels, inhibiting thrombosis, suppressing oxidative stress, attenuating nitric oxide induced damage, protecting the blood brain barrier and the neurovascular unit. However, which of the active compounds is responsible for its therapeutic effects is still unknown. Emerging studies have screened and tested these active compounds aiming to find individual compounds that can be used as drugs to treat stroke. The present study summarized both clinical evidence of XXMD in managing stroke and experimental evidence on its molecular mechanisms that have been reported recently using advanced techniques. A new perspective has also been discussed with an aim to provide new targets that can be used for screening active compounds from XXMD.
KW - active compound
KW - effective compound group
KW - ischemic stroke
KW - molecular mechanism
KW - pericytes
KW - xiaoxuming decoction
UR - http://www.scopus.com/inward/record.url?scp=85121880490&partnerID=8YFLogxK
U2 - 10.3389/fphar.2021.802381
DO - 10.3389/fphar.2021.802381
M3 - Review Article
C2 - 34970152
AN - SCOPUS:85121880490
SN - 1663-9812
VL - 12
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 802381
ER -